All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
CARDIO DIAGNOSTICS HOLDINGS, INC. Last Reported: 1/31/2024 Stock Symbol: CDIOW

Business Address

311 W. SUPERIOR STREET
SUITE 444
CHICAGO , IL US 60645

Mailing Address

311 W. SUPERIOR STREET
SUITE 444
CHICAGO , IL US 60645
Phone Number: 855-226-9991 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021
Cash and Cash Equivalents -- -- -- -- -- --
Accounts Receivable Net Current $350.00 $1,050.00 -- -- -- --
Inventory -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $892,300.00 $1,209,340.00 $1,768,366.00 -- -- --
Total Current Assets $4,522,298.00 $6,254,718.00 $5,885,887.00 $228,052.00 $186,119.00 $806,682.00
Property Plant and Equipement $37,233.00 $26,019.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- --
Goodwill -- -- -- -- -- --
Other Assets -- -- -- -- -- --
Total Assets $5,963,307.00 $6,756,904.00 $6,249,478.00 $65,801,435.00 $65,196,852.00 $65,807,166.00
Accounts Payable -- -- -- -- -- --
Accrued Liabilities -- -- -- $1,980.00 $5,000.00 --
Total Current Liabilities $3,675,576.00 $3,848,380.00 $1,947,770.00 $631,748.00 $229,434.00 $124,434.00
Long Term Debt -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- --
Accumulated Deficit $-12,979,451.00 $-11,047,069.00 $-5,991,546.00 $-747,931.00 $-860,151.00 $-144,837.00
Total Stockholders' Equity $2,287,731.00 $2,908,524.00 $4,301,708.00 $-353,696.00 $-32,582.00 $682,732.00
Controlling Interest in Subsidiaries -- -- -- -- -- --
Total Liabilities and Equity $5,963,307.00 $6,756,904.00 $6,249,478.00 $65,801,435.00 $65,196,852.00 $65,807,166.00

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021
Total Revenues $11,755.00 $1,725.00 $950.00 -- -- --
Cost of Revenues -- -- -- -- -- --
Gross Profit -- -- -- -- -- --
Research and Development $38,708.00 $98,982.00 $40,448.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- --
Total Operating Expenses $5,712,216.00 $4,257,995.00 $4,549,401.00 -- -- --
Loss from Operations $-5,700,461.00 $-4,256,270.00 $-4,548,451.00 $-890,962.00 $-725,671.00 $-145,321.00
Loss Before Income Taxes $-6,987,905.00 $-4,022,905.00 $-4,660,985.00 $202,269.00 $-715,314.00 $-144,837.00
Earnings Per Share Basic $-0.66 $-0.51 $-1.51 -- -- --
Weighted Average Shares Basic 10,573,070 9,896,724 3,087,683 -- -- --
Earnings Per Share Diluted $-0.66 $-0.51 $-1.51 -- -- --
Weighted Average Shares Diluted 10,573,070 10,242,430 3,087,683 -- -- --
Common Stock Shares Authorized 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000
Common Stock Shares Outstanding 13,117,325 11,178,455 9,514,743 1,625,000 1,625,000 1,625,000
Common Stock Value $131.00 $112.00 $95.00 $16.00 $16.00 $16.00
Common Stock Par Or Stated Value Per Share -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- --
Preferred Stock Shares Authorized 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000
Preferred Stock Shares Outstanding -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- --
Share Price -- -- -- -- -- --
Copyright 2024 PursePoor.com